Browse > Article

Apoptosis and Expressions of Apoptosis-Related Factors in Salivary Gland Tumors  

Yoon Hye-Kyoung (Departments of Pathology, Pusan Paik Hospital, Inje University)
Kang Mi-Seon (Departments of Pathology, Pusan Paik Hospital, Inje University)
Yi Jae-Woo (Departments of Pathology, Pusan Paik Hospital, Inje University)
Kim Sang-Hyo (Departments of Surgery, Pusan Paik Hospital, Inje University)
Publication Information
Korean Journal of Head & Neck Oncology / v.22, no.1, 2006 , pp. 15-22 More about this Journal
Abstract
Objectives: The salivary gland tumor shows heterogeneity in histologic patterns and biological behavior. The aim of this study is to elucidate the relationships between apoptosis and expressions of apoptosis-related factors(bcl-2, bax, M30), p53 and MIB-1 in the salivary gland tumors. Methods: Immunohistochemical stains for apoptosis-related factors, p53 and MIB-1 and TUNEL study for apoptosis were performed in 46 cases of salivary gland tumors 02 benign and 34 malignant). Results: Twenty(43.5%) of 46 cases showed positive reaction for apoptosis, and the expression rates of bcl-2, bax, M30, p53 and MIB-1 were 85.3%, 68.8%, 65.9%, 39.1% and 26.1%, respectively. A significant difference between benign and malignant tumors was only noted in MIB-1 expression(p=0.0167). In malignant tumors, apoptosis showed no significant relationships to expressions of apoptosis-related factors. There were inverse relationships between p53 and bcl-2 expression(p=0.0375), and between M30 and MIB-1 expressions(p=0.0379). No significant differences of apoptosis, bcl-2, bax, M30, p53 and MIB-1 expression rates according to the tumor size, lymph node status, recurrence and survival were found. Conclusion: In the development of benign and malignant salivary gland tumors, apoptosis might be associated, however, apoptosis and expressions of apoptosis-related factors seemed to be not reliable prognostic factors in malignant salivary gland tumors.
Keywords
Apoptosis; bcl-2; bax; M30; p53; MIB-1; Salivary gland;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Kayaselcuk F, Nursal TZ, Polat A, et al: Expression of survivin, bcl-2, p53 and bax in breast carcinoma and ductal intraepithelial neoplasia (DIN 1a). J Exp Clin Cancer Res. 2004;23:105-112
2 Karja VJ, Syrjanen KJ, Kurvinen A-K, Syrjanen SM: Expression and mutations of p53 in salivary gland tumors. J Oral Pathol Med. 1997;26:217-223   DOI   ScienceOn
3 Kapuccuglu N, Losi L, Eusebi V: Immunohistochemical localization of Bcl-2 and Bax proteins in in situ and invasive duct breast carcinomas. Virchows Arch. 1997;430:17-22   DOI   ScienceOn
4 Gerdes J, Lemke H, Baisch H, Wacker HH, Schwab U, Stein H: Cell cycle analysis of a cell proliferation associated human nuclear antigen defined by the monoclonal antibody Ki-67. J Immunol. 1984;133:1710-1715
5 Miyashita T, Reed JC: Tumor suppressor p53 is a direct transcriptional activator of the human bax gene. Cell. 1995;80:293-299   DOI   ScienceOn
6 Reed JC: Bcl-2 and the regulation of programmed cell death. J Cell Biol. 1994;124:1-6   DOI
7 Nagao T, Sugano I, Ishida Y, et al. Basal cell adenocarcinoma of the salivary glands: comparison with basal cell adenoma through assessment of cell proliferation, apoptosis, and expression of p53 and bcl-2. Cancer. 1998;82:439-447   DOI   ScienceOn
8 Soini Y, Tormanen U, Paakko P: Apoptosis is inversely related to bcl-2 but not to bax expression in salivary gland tumours. Histopathology. 1998;32:28-34   DOI   ScienceOn
9 Yin HF, Okada N, Takagi M: Apoptosis and apoptotic-related factors in mucoepidermoid carcinoma of the oral minor salivary glands. Pathol Int. 2000;50:603-609   DOI   ScienceOn
10 Kerr JF, Winterford CM, Harmon BV: Apoptosis. Its significance in cancer and cancer therapy. Cancer. 1994;73;2013-2036   DOI   ScienceOn
11 Garrity MM, Burgart LJ, Mahoney MR, et al: Prognostic value of proliferation, apoptosis, defective DNA mismatch repair, and p53 overexpression in patients with resected Dukes' B2 or C colon cancer: a North Central Cancer Treatment Group Study. J Clin Oncol. 2004;22:1572-1582   DOI   ScienceOn
12 Hockenbery DM: bcl-2 in cancer, development and apoptosis. J Cell Sci. 1994;18:51-55
13 Yang J, Liu X, Bhalla K, et al: Prevention of apoptosis by bcl-2: release of cytochrome c from mitochondria blocked. Science. 1997;275:1129-1132   DOI   ScienceOn
14 Baretton GB, Diebold J, Christoforis G, et al: Apoptosis and immunohistochemical bcl-2 expression in colorectal adenomas and carcinomas. Aspects of carcinogenesis and prognostic significance. Cancer. 1996;77:255-264   DOI   ScienceOn
15 Jia L, Esguerra RL, Tang X, et al: Prognostic value of apoptosis and apoptosis-associated proteins in salivary gland adenoid cystic carcinoma. Pathol Int. 2004;54:217-223   DOI   ScienceOn
16 Kroemer G: The proto-oncogene bcl-2 and its role in regulation of apoptosis. Nature Med. 1997;3:614-620   DOI   ScienceOn
17 Xin W, Paulino AF: Prognostic factors in malignant mixed tumors of the salivary gland: correlation of immunohistochemical markers with histologic classification. Ann Diagn Pathol. 2002; 6:205-210   DOI   ScienceOn
18 Yanez M, Roa I, Garcia M, Ibacache G, Villaseca M: Bcl-2 gene protein expression in salivary gland tumors. Rev Med Chil. 1999; 127:139-142
19 Pammer J, Horvat R, Weninger W, Ulrich W: Expression of bel-2 in salivary glands and salivary gland adenomas. A contribution to the reserve cell theory. Res Pract. 1995;191:35-41   DOI
20 Kusama K, Jiang Y, Toguchi M, et al: Use of the monoclonal antibody M30 for detecting HSG cell apoptosis. Anticancer Res. 2000;20:151-154